Authors

• Rui Liu (ORCID: https://orcid.org/0009-0006-8454-7645)
• Ke Su (ORCID: https://orcid.org/0000-0002-7948-6335)
• Shucheng Shen
• Shanshan Du (ORCID: https://orcid.org/0009-0005-5553-1671)
• Peng Sun (ORCID: https://orcid.org/0000-0002-0615-2510)
• Xin Liu (ORCID: https://orcid.org/0009-0004-7970-2327)
• Zhenjiang Li (ORCID: https://orcid.org/0000-0002-1100-7297)
• Rui Zhang (ORCID: https://orcid.org/0000-0002-4221-1311)
• Jian Chen (ORCID: https://orcid.org/0000-0003-3477-6045)
• Yong Yin (ORCID: https://orcid.org/0000-0003-1090-4313)
• Huadong Wang
• Heran Wang (ORCID: https://orcid.org/0000-0001-5376-087X)
• Yanze Li (ORCID: https://orcid.org/0000-0001-6989-8128)
• Benzhe Liang

Institutions

• Harbin Medical University (CN)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Shandong Normal University (CN)
• Affiliated Hospital of Southwest Medical University (CN)
• National Cancer Center (US)
• Third Affiliated Hospital of Harbin Medical University (CN)
• Nanjing Drum Tower Hospital (CN)
• Shandong First Medical University (CN)
• China Medical University (CN)
• University of South China (CN)

Publication Details

Journal

Frontiers in Immunology

Published

2025-10-23

DOI

https://doi.org/10.3389/fimmu.2025.1655803

Primary Topic

Pancreatic and Hepatic Oncology Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Natural Science Foundation of China
• Natural Science Foundation of Shandong Province